A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

Clinical trial NCT00870974 · COMPLETED

Trial details

NCT number: NCT00870974
Sponsor: Institute for Neurodegenerative Disorders
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson Disease Huntington Disease Autistic Spectrum Disorders Fragile X Syndrome Alzheimer Disease Mild Cognitive Impairment

Start date: 2009-03-01
Primary completion: 2016-10-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.